- Home
- J vs NBIX Comparison
J vs NBIX Comparison
Compare J & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- J
- NBIX
- Stock Information
- Founded
- J 1947
- NBIX 1992
- Country
- J United States
- NBIX United States
- Employees
- J N/A
- NBIX N/A
- Industry
- J Military/Government/Technical
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- J Industrials
- NBIX Health Care
- Exchange
- J Nasdaq
- NBIX Nasdaq
- Market Cap
- J 17.5B
- NBIX 14.4B
- IPO Year
- J N/A
- NBIX 1996
- Fundamental
- Price
- J $155.56
- NBIX $136.19
- Analyst Decision
- J Buy
- NBIX Strong Buy
- Analyst Count
- J 8
- NBIX 17
- Target Price
- J $154.57
- NBIX $163.71
- AVG Volume (30 Days)
- J 718.2K
- NBIX 895.4K
- Earning Date
- J 11-18-2025
- NBIX 10-29-2025
- Dividend Yield
- J 0.82%
- NBIX N/A
- EPS Growth
- J N/A
- NBIX 2.97
- EPS
- J 4.00
- NBIX 3.39
- Revenue
- J $11,835,289,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- J N/A
- NBIX $20.75
- Revenue Next Year
- J $6.63
- NBIX $14.73
- P/E Ratio
- J $38.80
- NBIX $40.40
- Revenue Growth
- J 61.50
- NBIX 18.42
- 52 Week Low
- J $105.18
- NBIX $84.23
- 52 Week High
- J $157.18
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- J 69.27
- NBIX 45.70
- Support Level
- J $147.52
- NBIX $135.59
- Resistance Level
- J $155.90
- NBIX $148.00
- Average True Range (ATR)
- J 2.69
- NBIX 3.15
- MACD
- J 0.69
- NBIX -1.16
- Stochastic Oscillator
- J 84.71
- NBIX 6.69
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $11.5 billion in revenue in fiscal 2024.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.